A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors

NCT05010525 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class

Stopped Based on the adjustment of clinical research and development strategy，sponsor decided to terminate the study

Conditions

Interventions

Sponsor

Shanghai Antengene Corporation Limited